Editorial [Hot Topic: New Treatment Strategies in Schizophrenia Beyond Dopamine: Glutamatergic Neurotransmission and More (Guest Editor: Christoph Mulert & Elizabeth Scarr)]

C.      Mulert

Author(s): C. Mulert

Volume 13, Issue 8, 2012

Page: [1474 - 1475] Pages: 2

DOI: 10.2174/138920112800784871

« Previous Next »

Download Options

Rights & Permissions Print Cite

Current Pharmaceutical Biotechnology

Title:Editorial [Hot Topic: New Treatment Strategies in Schizophrenia Beyond Dopamine: Glutamatergic Neurotransmission and More (Guest Editor: Christoph Mulert & Elizabeth Scarr)]

Volume: 13 Issue: 8

Author(s): C. Mulert

Affiliation:

Export Options

Export File:

RIS (for EndNote, Reference Manager, ProCite)

BibTeX

Text

Content:

Citation Only

Citation and Abstract

About this article

Cite this article as:

Mulert C., Editorial [Hot Topic: New Treatment Strategies in Schizophrenia Beyond Dopamine: Glutamatergic Neurotransmission and More (Guest Editor: Christoph Mulert & Elizabeth Scarr)], Current Pharmaceutical Biotechnology 2012; 13 (8) . https://dx.doi.org/10.2174/138920112800784871

DOI https://dx.doi.org/10.2174/138920112800784871	Print ISSN 1389-2010
Publisher Name Bentham Science Publisher	Online ISSN 1873-4316

About this journal

Call for Papers in Thematic Issues

Submission closes on : 01 June, 2024

Artificial Intelligence in Bioinformatics

Bioinformatics is an interdisciplinary field that analyzes and explores biological data. This field combines biology and information system. Artificial Intelligence (AI) has attracted great attention as it tries to replicate human intelligence. It has become common technology for analyzing and solving complex data and problems and encompasses sub-fields of machine ...read more

Guest Editor(s): Yan Pei